ArticleBMC infectious diseases2010
Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study.
Article in BMC infectious diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Article
- Fourteen years' clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy.Human vaccines & immunotherapeutics · 2021Article
- Rotavirus and Norovirus in Pediatric Healthcare-Associated Gastroenteritis.Open forum infectious diseases · 2016Article
- Nosocomial rotavirus infection: An up to date evaluation of European studies.Human vaccines & immunotherapeutics · 2016Review
- Temporal trends in hospitalization for rotavirus gastroenteritis: A nationwide study in Italy, 2005-2012.Human vaccines & immunotherapeutics · 2016Article
- Role of vaccination in the sustainability of healthcare systems.Journal of market access & health policy · 2015Article
- The Economic Value of Vaccination: Why Prevention is Wealth.Journal of market access & health policy · 2015Article
- Do current cost-effectiveness analyses reflect the full value of childhood vaccination in Europe? A rotavirus case study.Human vaccines & immunotherapeutics · 2014Review
- Article
- Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010.Archives of medical science : AMS · 2013Article
- Easily removable ureteral catheters for internal drainage in children: a preliminary report.Yonsei medical journal · 2013Article
- Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012Review
- Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis.European journal of pediatrics · 2012Article
- The economic burden of patient safety targets in acute care: a systematic review.Drug, healthcare and patient safety · 2012Article
- Biomagnetic techniques for evaluating gastric emptying, peristaltic contraction and transit time.World journal of gastrointestinal pathophysiology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFew data are available on the incidence of nosocomial Rotavirus infections (NRVI) in pediatric hospitals and on their economic impact. The goals of this study were: to evaluate the incidence of NRVI in various Italian pediatric wards during the course of two peak RV seasons; to investigate possible risk factors for NRVI; to estimate the costs caused by NRVI.
methodsprospective cohort study. POPULATION: All the children under 30 months of age who were admitted without any symptom or diagnosis of gastroenteritis in the pediatric hospitals of Florence, Naples, Brescia and Ancona, Italy, during the winter-spring periods 2006-2007 and 2007-2008. Serial RV rapid tests and clinical monitoring were carried out on the cohort. Telephone interviews were performed from 3 to 5 days after discharge.
results520 out of 608 children completed the study (85.6%). The overall incidence of NRVI was 5.3% (CI95% 3.6-7.5), (7.9 per 1,000 days of hospital stay, CI 95% 5.3-11.3). The average duration of hospital stay was significantly longer for children who had NRVI (8.1 days, SD 5.4) than for non-infected children (6.4 days, SD 5.8, difference 1.7 days, p = 0.004). The risk of contracting NRVI increased significantly if the child stayed in hospital more than 5 days, RR = 2.8 (CI95% 1.3-6), p = 0.006. In Italy the costs caused by NRVI can be estimated at 8,019,155.44 Euro per year. 2.7% of the children hospitalized with no gastroenteritis symptoms tested positive for RV.
conclusionsOur study showed a relevant incidence of NRVI, which can increase the length of the children's stay in hospital. Limiting the number of nosocomial RV infections is important to improve patients' safety as well as to avoid additional health costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.